BFPW
GSK icon

BOK Financial Private Wealth’s GSK GSK Stock Holding History

BOK Financial Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$94.4K Buy
1,786
+186
+12% +$9.84K ﹤0.01% 232
2026
Q1 		$89.1K Hold
1,600
– – 0.01% 227
2025
Q4 		$79.2K Hold
1,600
– – ﹤0.01% 245
2025
Q3 		$69.7K Hold
1,600
– – ﹤0.01% 229
2025
Q2 		$62.1K Sell
1,600
-112
-7% -$4.28K ﹤0.01% 234
2025
Q1 		$67.7K Sell
1,712
-1,600
-48% -$58.6K 0.01% 239
2024
Q4 		$113K Buy
3,312
+1
+0% +$36 0.01% 199
2024
Q3 		$137K Buy
3,311
+1
+0% +$41 0.01% 193
2024
Q2 		$129K Buy
3,310
+1
+0% +$42 0.01% 190
2024
Q1 		$143K Buy
3,309
+1
+0% +$41 0.01% 187
2023
Q4 		$124K Buy
3,308
+108
+3% +$3.88K 0.01% 188
2023
Q3 		$117K Hold
3,200
– – 0.01% 179
2023
Q2 		$115K Sell
3,200
-99
-3% -$3.55K 0.01% 183
2023
Q1 		$118K Buy
3,299
+99
+3% +$3.46K 0.01% 185
2022
Q4 		$115K Sell
3,200
-3,718
-54% -$124K 0.01% 184
2022
Q3 		$206K Hold
6,918
– – 0.02% 169
2022
Q2 		$379K Sell
6,918
-388
-5% -$21.4K 0.03% 140
2022
Q1 		$398K Sell
7,306
-60
-0.8% -$3.26K 0.03% 193
2021
Q4 		$406K Buy
+7,366
New +$383K 0.03% 190

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

BOK Financial Private Wealth's GSK Position: Q2 2026 in Review

BOK Financial Private Wealth increased its GSK (GSK) stake by 12% in Q2 2026, buying an estimated $9.84K and bringing the position to 1,786 shares worth $94.4K. The position accounts for ﹤0.01% of the portfolio, ranked #232.

BOK Financial Private Wealth first reported a position in GSK in Q4 2021 and has held it in 19 quarters since. The position peaked at $406K in Q4 2021. 1,043 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • BOK Financial Private Wealth held 1,786 shares of GSK worth $94.4K as of Q2 2026.
  • BOK Financial Private Wealth bought 186 GSK shares in Q2 2026, an estimated $9.84K.
  • GSK made up ﹤0.01% of BOK Financial Private Wealth's portfolio in Q2 2026, its #232 holding.
  • BOK Financial Private Wealth first reported a position in GSK in Q4 2021 and has held it in 19 quarters since.
  • BOK Financial Private Wealth's GSK position peaked at $406K in Q4 2021.
  • 1,043 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on BOK Financial Private Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.